m+Medelevator.RU
← Поиск публикаций
Advanced materials (Deerfield Beach, Fla.) · 2026

Hypertemperature-Detonated Biomimetic Semiconductor Stromal Bombs for Enhanced Immunotherapy in Pancreatic Cancer.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Xie Chengke, Zhu Houjuan, Wen Jianfan, Mo Yichao, Wang Wanwan, Yu Chan Chui, Lin Xinquan, Huang Xiaoxiao, Li Ge, Wu Yongding, Fan Xiaotong, Jie Zheng, Yan Maolin, Li Zhiyuan, Wang Zuwei, Heng Jerry Zhi Xiong, Tang Karen Yuanting, Tian Yifeng, Ye Enyi, Jun Loh Xian, Li Zibiao, Liao Chengyu, Chen Shi

Аннотация

Pancreatic ductal adenocarcinoma (PDAC) is characterized by "copper avidity", which easily leads to the dysregulation of copper ion homeostasis. It is possible to develop targeted nanodrugs that selectively kill cancer cells via cuproptosis. However, the dense stroma of PDAC acts as an airtight wall, which not only limits the penetration and distribution of therapeutic agents but also promotes immunosuppressive mechanisms via its hypoxia-promoting effects, often leading to treatment failure. Thus, we developed a near-infrared (NIR)-responsive semiconductor polymer-metal‒organic framework (MOF) nanoreactor (SPNMCH) that was loaded with copper sulfide nanoclusters (CuSx NCs) and hyaluronidase (HAase). This biomimetic semiconductor "bomb" extensively demolishes the wall (by highly activating HAase) and precisely eliminates tumor cells (through its active copper uptake to induce cuproptosis). Simultaneously, the synergistic effects of increased oxygen delivery and cuproptosis elicit robust antitumor immune responses to inhibit tumor progression and distant metastasis, and strong immune memory effects as observed in four mouse cancer models. Additionally, SPNMCH can be combined with anti-programmed death receptor 1 (PD-1) antibodies to further promote T cell-mediated antitumor immunity. This study reveals a promising strategy for establishing a "hot" tumor immune niche in PDAC to promote the response to immunotherapy.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты